Gene expression profiling by mRNA sequencing reveals increased expression of immune/inflammation-related genes in the hippocampus of individuals with schizophrenia
Adult
Male
0301 basic medicine
Antigens, Differentiation, Myelomonocytic
612
Hippocampus
03 medical and health sciences
Antigens, CD
Humans
RNA, Messenger
Oligonucleotide Array Sequence Analysis
Inflammation
Gene Expression Profiling
Membrane Proteins
RNA-Binding Proteins
Middle Aged
Apolipoprotein L1
Antigens, Differentiation
3. Good health
Apolipoproteins
Insulin-Like Growth Factor Binding Protein 4
Case-Control Studies
Original Article
Female
Lipoproteins, HDL
DOI:
10.1038/tp.2013.94
Publication Date:
2013-10-29T14:34:59Z
AUTHORS (8)
ABSTRACT
Whole-genome expression profiling in postmortem brain tissue has recently provided insight into the pathophysiology of schizophrenia. Previous microarray and RNA-Seq studies identified several biological processes including synaptic function, mitochondrial function and immune/inflammation response as altered in the cortex of subjects with schizophrenia. Now using RNA-Seq data from the hippocampus, we have identified 144 differentially expressed genes in schizophrenia cases as compared with unaffected controls. Immune/inflammation response was the main biological process over-represented in these genes. The upregulation of several of these genes, IFITM1, IFITM2, IFITM3, APOL1 (Apolipoprotein L1), ADORA2A (adenosine receptor 2A), IGFBP4 and CD163 were validated in the schizophrenia subjects using data from the SNCID database and with quantitative RT-PCR. We identified a co-expression module associated with schizophrenia that includes the majority of differentially expressed genes related to immune/inflammation response as well as with the density of parvalbumin-containing neurons in the hippocampus. The results indicate that abnormal immune/inflammation response in the hippocampus may underlie the pathophysiology of schizophrenia and may be associated with abnormalities in the parvalbumin-containing neurons that lead to the cognitive deficits of the disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (82)
CITATIONS (166)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....